PPF
VRTX icon

PFA Pension Forsikringsaktieselskab’s Vertex Pharmaceuticals VRTX Stock Holding History

PFA Pension Forsikringsaktieselskab’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.7M Sell
93,959
-41,037
-30% -$18.2M 0.12% 195
2026
Q1 		$60.3M Sell
134,996
-192
-0.1% -$89.5K 0.18% 142
2025
Q4 		$61.3M Buy
+135,188
New +$58.3M 0.17% 155

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

PFA Pension Forsikringsaktieselskab's VRTX Position: Q2 2026 in Review

PFA Pension Forsikringsaktieselskab reduced its Vertex Pharmaceuticals (VRTX) stake by 30% in Q2 2026, selling an estimated $18.2M and leaving 93,959 shares worth $46.7M. The position accounts for 0.12% of the portfolio, ranked #195.

PFA Pension Forsikringsaktieselskab first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $61.3M in Q4 2025. 1,355 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • PFA Pension Forsikringsaktieselskab held 93,959 shares of Vertex Pharmaceuticals worth $46.7M as of Q2 2026.
  • PFA Pension Forsikringsaktieselskab sold 41,037 Vertex Pharmaceuticals shares in Q2 2026, an estimated $18.2M.
  • Vertex Pharmaceuticals made up 0.12% of PFA Pension Forsikringsaktieselskab's portfolio in Q2 2026, its #195 holding.
  • PFA Pension Forsikringsaktieselskab first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • PFA Pension Forsikringsaktieselskab's Vertex Pharmaceuticals position peaked at $61.3M in Q4 2025.
  • 1,355 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on PFA Pension Forsikringsaktieselskab's 13F filing for Q2 2026, filed 12 Aug 2026.